| 1.9 |
21.0 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 1.3 |
4.0 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 1.2 |
3.6 |
GO:0090425 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 1.2 |
3.5 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.1 |
3.4 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) regulation of interleukin-6-mediated signaling pathway(GO:0070103) negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 1.0 |
4.2 |
GO:0055099 |
regulation of Cdc42 protein signal transduction(GO:0032489) response to high density lipoprotein particle(GO:0055099) platelet dense granule organization(GO:0060155) |
| 1.0 |
2.9 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.9 |
1.9 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.8 |
2.4 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.8 |
4.0 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.7 |
6.0 |
GO:0071732 |
cellular response to nitric oxide(GO:0071732) |
| 0.7 |
26.3 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.7 |
5.6 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.7 |
3.4 |
GO:0046684 |
response to pyrethroid(GO:0046684) |
| 0.6 |
3.0 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
| 0.6 |
2.9 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) |
| 0.6 |
4.1 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 |
5.8 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.5 |
1.6 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.5 |
1.0 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) interferon-beta biosynthetic process(GO:0045350) regulation of interferon-alpha biosynthetic process(GO:0045354) regulation of interferon-beta biosynthetic process(GO:0045357) negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.5 |
2.0 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.5 |
13.9 |
GO:0022401 |
desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
| 0.5 |
3.8 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.5 |
1.9 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.5 |
0.9 |
GO:0098657 |
neurotransmitter uptake(GO:0001504) import into cell(GO:0098657) |
| 0.5 |
2.4 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.5 |
1.4 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 |
1.3 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.4 |
1.3 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.4 |
1.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.4 |
1.2 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 |
1.9 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 0.4 |
9.0 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.4 |
1.1 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.4 |
1.5 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.4 |
1.1 |
GO:0003349 |
epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
| 0.4 |
1.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.4 |
1.8 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.3 |
3.4 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.3 |
3.0 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.3 |
1.0 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.3 |
3.0 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.3 |
3.2 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.3 |
1.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.3 |
1.8 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.3 |
1.5 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.3 |
1.8 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
3.2 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 |
0.9 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.3 |
1.1 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.3 |
2.5 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.3 |
2.0 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
| 0.3 |
0.8 |
GO:0034241 |
positive regulation of macrophage fusion(GO:0034241) regulation of osteoclast proliferation(GO:0090289) |
| 0.3 |
1.0 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.3 |
6.2 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.3 |
1.0 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.3 |
1.0 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.2 |
1.2 |
GO:0021993 |
initiation of neural tube closure(GO:0021993) |
| 0.2 |
0.7 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.2 |
0.9 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 |
0.9 |
GO:0060032 |
notochord regression(GO:0060032) |
| 0.2 |
0.7 |
GO:0043201 |
response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.2 |
0.7 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.2 |
1.1 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.2 |
1.1 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.2 |
0.9 |
GO:0061010 |
gall bladder development(GO:0061010) |
| 0.2 |
0.7 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.2 |
1.7 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.2 |
1.1 |
GO:0044838 |
cell quiescence(GO:0044838) |
| 0.2 |
1.9 |
GO:1902287 |
semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.2 |
1.1 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.2 |
1.5 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.2 |
1.1 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.2 |
2.1 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.3 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.2 |
2.1 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.2 |
0.6 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.2 |
1.0 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.2 |
1.2 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.2 |
0.6 |
GO:2001180 |
negative regulation of interleukin-18 production(GO:0032701) negative regulation of interleukin-10 secretion(GO:2001180) |
| 0.2 |
1.4 |
GO:0032196 |
transposition(GO:0032196) |
| 0.2 |
0.6 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.2 |
1.2 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.2 |
1.2 |
GO:0006046 |
N-acetylglucosamine catabolic process(GO:0006046) |
| 0.2 |
0.8 |
GO:0043651 |
linoleic acid metabolic process(GO:0043651) |
| 0.2 |
0.8 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.6 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.2 |
0.8 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
1.5 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 |
1.3 |
GO:0060576 |
intestinal epithelial cell development(GO:0060576) |
| 0.2 |
0.2 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 |
1.5 |
GO:0002674 |
negative regulation of acute inflammatory response(GO:0002674) |
| 0.2 |
0.7 |
GO:1903251 |
multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.2 |
2.4 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
| 0.2 |
1.1 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 0.2 |
1.9 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.2 |
0.5 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.2 |
1.9 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 0.2 |
1.2 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.2 |
1.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.2 |
0.5 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
0.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.7 |
GO:0014012 |
negative regulation of Schwann cell proliferation(GO:0010626) peripheral nervous system axon regeneration(GO:0014012) |
| 0.2 |
0.5 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.2 |
1.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.2 |
0.6 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
0.6 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.2 |
2.0 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.2 |
0.8 |
GO:0003344 |
pericardium morphogenesis(GO:0003344) |
| 0.2 |
0.6 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
1.0 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
1.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
1.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
1.1 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.6 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.4 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
1.1 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
0.7 |
GO:0072539 |
T-helper 17 cell differentiation(GO:0072539) |
| 0.1 |
0.4 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
0.3 |
GO:0030214 |
hyaluronan catabolic process(GO:0030214) |
| 0.1 |
0.4 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.1 |
0.6 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.1 |
GO:0034238 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
| 0.1 |
0.1 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 |
0.4 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.1 |
3.1 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
0.4 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
1.1 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.7 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
0.5 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.1 |
0.9 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.7 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.1 |
1.7 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
| 0.1 |
0.2 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.3 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.1 |
1.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.7 |
GO:0042270 |
protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.1 |
1.2 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.1 |
0.2 |
GO:1901856 |
negative regulation of cellular respiration(GO:1901856) |
| 0.1 |
0.4 |
GO:2001045 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.1 |
0.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.7 |
GO:0051503 |
adenine nucleotide transport(GO:0051503) |
| 0.1 |
1.0 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
| 0.1 |
0.7 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 |
2.2 |
GO:0046466 |
membrane lipid catabolic process(GO:0046466) |
| 0.1 |
1.4 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.1 |
0.4 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.1 |
1.6 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.1 |
0.9 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
1.5 |
GO:0030033 |
microvillus assembly(GO:0030033) |
| 0.1 |
0.4 |
GO:1902268 |
negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 |
0.4 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
2.6 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.4 |
GO:0034116 |
positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
| 0.1 |
1.3 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
1.6 |
GO:0019184 |
nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.1 |
0.2 |
GO:1903371 |
regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.1 |
0.7 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.1 |
0.3 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.1 |
0.3 |
GO:0046013 |
T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.1 |
0.3 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.4 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.1 |
0.7 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.1 |
1.3 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.1 |
0.3 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.1 |
0.8 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
1.2 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.1 |
0.2 |
GO:0060437 |
lung growth(GO:0060437) |
| 0.1 |
0.2 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.1 |
0.2 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 |
0.3 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
1.0 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.1 |
1.0 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
0.7 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.1 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.4 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.1 |
0.2 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.1 |
0.8 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.5 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.1 |
1.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.1 |
1.6 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 |
0.5 |
GO:0097341 |
inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
| 0.1 |
0.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.1 |
0.6 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
1.6 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
0.1 |
GO:0060023 |
soft palate development(GO:0060023) |
| 0.1 |
0.5 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.2 |
GO:0030950 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.1 |
0.3 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
3.9 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.1 |
1.3 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.1 |
0.7 |
GO:0019885 |
antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.1 |
0.5 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.1 |
GO:0060765 |
regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 |
2.0 |
GO:2001238 |
positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.1 |
0.3 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.1 |
0.9 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
0.6 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.5 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
1.2 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.1 |
1.1 |
GO:0006862 |
nucleotide transport(GO:0006862) |
| 0.1 |
1.7 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.1 |
0.3 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.1 |
0.7 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.1 |
0.2 |
GO:0030049 |
diaphragm contraction(GO:0002086) muscle filament sliding(GO:0030049) |
| 0.1 |
0.7 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.1 |
0.1 |
GO:0015911 |
plasma membrane long-chain fatty acid transport(GO:0015911) fatty acid transmembrane transport(GO:1902001) |
| 0.1 |
10.5 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.1 |
0.5 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.3 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.2 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
3.0 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 |
0.1 |
GO:0060665 |
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
| 0.1 |
0.8 |
GO:0032608 |
interferon-beta production(GO:0032608) |
| 0.1 |
0.1 |
GO:0046485 |
ether lipid metabolic process(GO:0046485) |
| 0.1 |
0.3 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.3 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.6 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
0.9 |
GO:1900153 |
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
| 0.1 |
0.6 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.8 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
0.2 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.1 |
2.9 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.1 |
0.7 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.7 |
GO:0090231 |
regulation of spindle checkpoint(GO:0090231) |
| 0.0 |
0.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.1 |
GO:2001179 |
interleukin-10 secretion(GO:0072608) regulation of interleukin-10 secretion(GO:2001179) positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.2 |
GO:1903347 |
negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.0 |
1.4 |
GO:0034243 |
regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
| 0.0 |
0.2 |
GO:0046210 |
nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.0 |
4.4 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.0 |
0.9 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.9 |
GO:0045725 |
positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 |
0.5 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.1 |
GO:0010845 |
positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.0 |
0.1 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.0 |
0.8 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.0 |
0.8 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.8 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.4 |
GO:0098907 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.0 |
0.1 |
GO:0071360 |
cellular response to exogenous dsRNA(GO:0071360) |
| 0.0 |
0.1 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.0 |
0.2 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.0 |
0.4 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.0 |
1.0 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.0 |
0.2 |
GO:0042640 |
anagen(GO:0042640) |
| 0.0 |
0.1 |
GO:0060368 |
regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.0 |
0.9 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.2 |
GO:0046068 |
cGMP metabolic process(GO:0046068) |
| 0.0 |
0.6 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
1.8 |
GO:0048477 |
oogenesis(GO:0048477) |
| 0.0 |
0.2 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.0 |
0.2 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.0 |
0.1 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.2 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
| 0.0 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
1.5 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.7 |
GO:0010453 |
regulation of cell fate commitment(GO:0010453) |
| 0.0 |
0.3 |
GO:0015838 |
amino-acid betaine transport(GO:0015838) |
| 0.0 |
0.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.0 |
0.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.6 |
GO:0042832 |
defense response to protozoan(GO:0042832) |
| 0.0 |
0.6 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
3.0 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.5 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.0 |
0.9 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 |
2.1 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
1.6 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 |
0.4 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.0 |
0.5 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.6 |
GO:0035567 |
non-canonical Wnt signaling pathway(GO:0035567) |
| 0.0 |
0.7 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 |
0.2 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.0 |
0.2 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.7 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.0 |
0.1 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.4 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 |
0.4 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
1.3 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.0 |
0.6 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.2 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.2 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.0 |
0.1 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.6 |
GO:0031952 |
regulation of protein autophosphorylation(GO:0031952) |
| 0.0 |
2.9 |
GO:0008643 |
carbohydrate transport(GO:0008643) |
| 0.0 |
0.4 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.3 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
0.5 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.0 |
0.1 |
GO:0035791 |
platelet-derived growth factor receptor-beta signaling pathway(GO:0035791) |
| 0.0 |
0.2 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.0 |
0.5 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.2 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.0 |
0.3 |
GO:0018208 |
peptidyl-proline modification(GO:0018208) |
| 0.0 |
0.5 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.0 |
0.1 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.0 |
0.5 |
GO:0003229 |
ventricular cardiac muscle tissue development(GO:0003229) |
| 0.0 |
0.4 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.0 |
0.4 |
GO:0030641 |
regulation of cellular pH(GO:0030641) regulation of intracellular pH(GO:0051453) |
| 0.0 |
0.2 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.6 |
GO:0061512 |
protein localization to cilium(GO:0061512) |
| 0.0 |
0.1 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.0 |
0.1 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.0 |
0.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.1 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) |
| 0.0 |
1.2 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.3 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
| 0.0 |
0.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.4 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.0 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.5 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.3 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 |
0.1 |
GO:1902969 |
mitotic DNA replication(GO:1902969) |
| 0.0 |
0.5 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.0 |
0.1 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.0 |
0.5 |
GO:0016239 |
positive regulation of macroautophagy(GO:0016239) |
| 0.0 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 0.0 |
0.1 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.0 |
0.1 |
GO:0051315 |
attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
| 0.0 |
0.1 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.0 |
0.7 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.6 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.0 |
0.9 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.3 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.0 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.2 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.3 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.0 |
0.0 |
GO:0051593 |
response to folic acid(GO:0051593) |
| 0.0 |
0.1 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.4 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.2 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.0 |
0.8 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.0 |
0.3 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.0 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.0 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.0 |
0.1 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.0 |
1.2 |
GO:0032868 |
response to insulin(GO:0032868) |
| 0.0 |
0.5 |
GO:0051209 |
release of sequestered calcium ion into cytosol(GO:0051209) regulation of sequestering of calcium ion(GO:0051282) negative regulation of sequestering of calcium ion(GO:0051283) |
| 0.0 |
0.1 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.1 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.0 |
0.1 |
GO:0060965 |
negative regulation of gene silencing by miRNA(GO:0060965) |
| 0.0 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.4 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
